Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Net Margin (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Net Margin for 12 consecutive years, with 68.21% as the latest value for Q1 2026.

  • For Q1 2026, Net Margin rose 44272.0% year-over-year to 68.21%; the TTM value through Mar 2026 reached 391.07%, down 34188.0%, while the annual FY2025 figure was 478.33%, 38876.0% down from the prior year.
  • Net Margin hit 68.21% in Q1 2026 for Wave Life Sciences, up from 580.17% in the prior quarter.
  • Across five years, Net Margin topped out at 14.78% in Q3 2023 and bottomed at 13685.61% in Q3 2022.
  • Average Net Margin over 5 years is 2055.81%, with a median of 189.58% recorded in 2023.
  • Year-over-year, Net Margin crashed -1366851bps in 2022 and then surged 1370040bps in 2023.
  • Wave Life Sciences' Net Margin stood at 53.83% in 2022, then skyrocketed by 76bps to 12.68% in 2023, then skyrocketed by 216bps to 14.66% in 2024, then crashed by -4057bps to 580.17% in 2025, then soared by 88bps to 68.21% in 2026.
  • According to Business Quant data, Net Margin over the past three periods came in at 68.21%, 580.17%, and 510.93% for Q1 2026, Q2 2025, and Q1 2025 respectively.